Kazia Therapeutics: Dauntless reports 5.42% stake

Dauntless reported sole power to dispose of its position but no sole or shared power to vote the shares.

Rhea-AI Filing Summary

KAZIA THERAPEUTICS LTD (KZIA) was the issuer in an ownership amendment reporting that Dauntless Investment Group, LLC beneficially owned 842,340 American Depository Shares, or 5.42% of the class. Dauntless reported sole dispositive power over 842,340 shares and zero sole or shared voting power. Matthew Okkerse, identified as CFO, signed the amendment.

Key Figures

Beneficial ownership: 842,340 American Depository Shares Percent of class: 5.42% Sole voting power: 0 shares +3 more

6 metrics

Beneficial ownership 842,340 American Depository Shares Dauntless Investment Group, LLC

Percent of class 5.42% Dauntless Investment Group, LLC

Sole voting power 0 shares Dauntless Investment Group, LLC

Shared voting power 0 shares Dauntless Investment Group, LLC

Sole dispositive power 842,340 shares Dauntless Investment Group, LLC

Shared dispositive power 0 shares Dauntless Investment Group, LLC

Key Terms

beneficially owned, sole dispositive power, shared voting power

3 terms

beneficially owned regulatory

"Amount beneficially owned: 842,340"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole Dispositive Power 842,340.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

shared voting power regulatory

"Shared voting power: 0"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KZIA American Depository Shares does Dauntless Investment Group report?

Dauntless Investment Group, LLC reported beneficial ownership of 842,340 American Depository Shares, equal to 5.42% of the class.

What voting and disposition powers did Dauntless report for KZIA?

Dauntless reported zero sole and shared voting power, sole dispositive power over 842,340 shares, and zero shared dispositive power.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 03:57 PM Accepted by SEC EDGAR 10/02/2026 - 03:56 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

KAZIA THERAPEUTICS LTD

(Name of Issuer)

American Depository Shares

(Title of Class of Securities)

48669G105

(CUSIP Number)

09/25/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 48669G105

1

Names of Reporting Persons

Dauntless Investment Group, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 842,340.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

842,340.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Single Family Office/Passive Investor

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KAZIA THERAPEUTICS LTD
(b)	Address of issuer's principal executive offices: Three International Towers, Level 24, 300 Barangaroo Avenue, SYDNEY NSW, AUSTRALIA, 2000.
Item 2.
(a)	Name of person filing: Dauntless Investment Group, LLC
(b)	Address or principal business office or, if none, residence: 3283 Foxfire Dr., Milford, MI 48380
(c)	Citizenship: Delaware
(d)	Title of class of securities: American Depository Shares
(e)	CUSIP No.: 48669G105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 842,340
(b)	Percent of class: 5.42%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 842,340
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dauntless Investment Group, LLC

Signature:	/s/Matthew Okkerse
Name/Title:	CFO
Date:	10/02/2026